Advertisement
BD Biosciences
BD Biosciences

The Scientist

» Big Pharma and culture

Most Recent

image: Cartographer of Metabolic Pathways Dies

Cartographer of Metabolic Pathways Dies

By | June 4, 2012

A biochemist who mapped the ways in which molecular pathways interact passed away at age 96.

2 Comments

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | June 1, 2012

The Aha! Moment, Imagine, Ignorance, and The Age of Insight

0 Comments

image: Book Excerpt from <em>The Mara Crossing</em>

Book Excerpt from The Mara Crossing

By | June 1, 2012

Author Ruth Padel tells the stories of John James Audubon and cellular migration in prose and verse

1 Comment

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Food's Afterlife

Food's Afterlife

By | May 25, 2012

Meals left to mold develop colors, mycelia, and beads of digested juices, sparking the eye of an artist, and the slight concern of a mycologist.

0 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

Check out the 10 images that won FASEB's first annual Bio-Art competition.

0 Comments

image: Lab Bench Beauty

Lab Bench Beauty

By | May 25, 2012

Ten scientist-produced images take top honors in the first annual Bio-Art competition.

0 Comments

image: Overhauling Industry-Sponsored Studies

Overhauling Industry-Sponsored Studies

By | May 23, 2012

Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.

1 Comment

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Simulating Scientific Sabotage, For Fun
  3. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Life Technologies